Fourth, we were unable to adjust for RA disease activity owing to a lack of clinical measures, such as Disease Activity Score-28, CRP levels, and erythrocyte sedimentation rate, in the claims database, which represents a major limitation. The gene discussed is CRP; the disease is rheumatoid arthritis.